Longeveron Inc. (LGVN) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
2.64
↓-20% vs avg
5yr avg: 3.30
30Y Low1.2·High6.1
ROE
↓
-164.7%
↑-41% vs avg
5yr avg: -117.0%
30Y Low-165%·High-65%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
LGVN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Longeveron Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $20M | $9M | $26M | $30M | $68M | $228M | — | — | — |
| Enterprise Value | $16M | $5M | $8M | $27M | $60M | $206M | — | — | — |
| P/E Ratio → | -0.66 | — | — | — | — | — | — | — | — |
| P/S Ratio | 16.56 | 7.42 | 10.77 | 41.69 | 55.25 | 174.81 | — | — | — |
| P/B Ratio | 2.64 | 1.57 | 1.18 | 4.39 | 3.29 | 6.10 | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
LGVN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.22 | 3.33 | 37.59 | 48.79 | 157.57 | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
LGVN Profitability
Margins and return-on-capital ratios measuring operating efficiency
Longeveron Inc. earns an operating margin of -1942.2%. Operating margins have expanded from -2966.0% to -1942.2% over the past 3 years, signaling improving operational efficiency. A negative ROE of -164.7% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.0% | 67.0% | 78.8% | 31.2% | 40.7% | 45.2% | 32.4% | 32.4% | 31.9% |
| Operating Margin | -1942.2% | -1942.2% | -690.7% | -2966.0% | -1476.5% | -1336.6% | -67.1% | -67.1% | -298.0% |
| Net Profit Margin | -1893.6% | -1893.6% | -667.8% | -3020.2% | -1541.3% | -1305.1% | -66.1% | -66.1% | -296.8% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -164.7% | -164.7% | -111.6% | -157.2% | -65.0% | -86.5% | -116.2% | -66.1% | -93.0% |
| ROA | -126.8% | -126.8% | -84.9% | -108.4% | -53.7% | -65.6% | -37.5% | -35.3% | -60.2% |
| ROIC | -588.1% | -588.1% | -312.3% | -191.9% | -98.3% | -129.5% | -47.2% | -59.7% | -171.4% |
| ROCE | -159.8% | -159.8% | -106.0% | -136.8% | -57.6% | -76.8% | -55.9% | -45.1% | -73.5% |
LGVN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $5M exceeds total debt of $824000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.15 | 0.15 | 0.07 | 0.30 | 0.13 | 0.08 | 2.12 | 0.93 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.68 | -0.81 | -0.43 | -0.39 | -0.60 | 1.70 | 0.51 | -0.59 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | -4260.25 | -567.80 | -21977.91 | — |
Net cash position: cash ($5M) exceeds total debt ($824000)
LGVN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.33x means Longeveron Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.50x to 1.33x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.33 | 1.33 | 7.60 | 1.50 | 4.17 | 13.06 | 0.48 | 0.95 | 2.24 |
| Quick Ratio | 1.33 | 1.33 | 7.60 | 1.50 | 4.17 | 13.06 | 0.48 | 0.95 | 2.24 |
| Cash Ratio | 1.14 | 1.14 | 7.45 | 1.38 | 4.04 | 12.94 | 0.21 | 0.75 | 2.16 |
| Asset Turnover | — | 0.12 | 0.09 | 0.06 | 0.04 | 0.03 | 0.61 | 0.53 | 0.20 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 31.66 | 12.82 | 57.14 | 65.11 | 15.37 | 27.23 | 29.27 | — |
LGVN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Longeveron Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 33.6% | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.6% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 33.6% | 0.6% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $18M | $15M | $2M | $2M | $2M | $2M | $2M | $2M |
Peer Comparison
Compare LGVN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 LGVNYou | $20M | -0.7 | — | — | 67.0% | -1942.2% | -164.7% | -588.1% | — |
 MESO | $2B | -17.6 | — | — | 70.2% | -363.1% | -19.0% | -8.5% | — |
 NKTR | $2B | -8.6 | — | — | 100.0% | -236.8% | -217.9% | -57.2% | — |
 BCLI | $7M | 0.3 | — | — | 100.0% | -1377.3% | — | — | — |
 PLUR | $27M | -0.9 | — | — | 49.0% | -1659.9% | -992.7% | -59.9% | — |
 FATE | $280M | -2.1 | — | — | — | -2222.4% | -51.8% | -36.5% | — |
 CELH | $9B | 137.0 | 18.2 | 27.2 | 50.4% | 18.6% | 5.2% | 19.7% | 1.3 |
 RCEL | $128M | -2.4 | 1.9 | — | 82.1% | 89.0% | — | 818.9% | 0.0 |
 MDXG | $548M | 11.5 | 5.1 | 7.5 | 82.6% | 15.3% | 21.6% | 42.3% | 0.3 |
 CRL | $9B | -62.5 | 13.0 | 17.3 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 |
 ICLR | $10B | 13.1 | 7.9 | 8.5 | 29.4% | 13.3% | 8.4% | 6.5% | 2.3 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
See LGVN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LGVN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LGVN vs MESO
Side-by-side business, growth, and profitability comparison vs Mesoblast Limited.
Start ComparisonLGVN — Frequently Asked Questions
Quick answers to the most common questions about buying LGVN stock.
What is Longeveron Inc.'s P/E ratio?
Longeveron Inc.'s current P/E ratio is -0.7x. This places it at the 50th percentile of its historical range.
What is Longeveron Inc.'s ROE?
Longeveron Inc.'s return on equity (ROE) is -164.7%. The historical average is -107.5%.
Is LGVN stock overvalued?
Based on historical data, Longeveron Inc. is trading at a P/E of -0.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Longeveron Inc.'s profit margins?
Longeveron Inc. has 67.0% gross margin and -1942.2% operating margin.